Primary Record
Everolimus
- In stock
- 1,172 g
- Purity
- 98.2 %
- CAS
- 159351-69-6
Compound Identifiers & Properties
- CAS
- 159351-69-6
- PubChem CID
- 18477728
- SMILES
- C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C\[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC
- Canonical SMILES
- CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C\C=C\C=C\1C
Names & Synonyms
- Everolimus
- Afinitor
- Certican
- Zortress
- Votubia
- Afinitor Disperz
- Everolimus [USAN]
- SDZ-RAD
- Afinitor (TN)
- Certican (TN)
- Everolimus Impurity 2
- MTOR kinase inhibitors
- XIENCE V
- SDZ RAD
- CERTICAN(R)
- Everolimus(RAD-001)
- RAD, SDZ
- 159351-69-6
- RAD 001
- RAD001
- D0K3QS
- 40-O-(2-hydroxyethyl)-rapamycin
- UNII-9HW64Q8G6G
- 40-O-(2-Hydroxyethyl)rapamycin
- 42-O-(2-Hydroxyethyl)rapamycin
- Everolimus (JAN/USAN/INN)
- Everolimus [USAN:INN:BAN]
- NVP-RAD-001
- RAD-001
- MFCD00929329
- 42-O-(2-Hydroxy)ethyl rapamycin
- C53H83NO14
- RAD-001C
- CHEMBL4079877
- Everolimus CRS (Y0002048)
- 001, RAD
- MSK10253
- Rapamycin, 42-O-(2-hydroxyethyl)-
- C53-H83-N-O14
- ZINC263623436
- ACN-035840
- AN-9977
- BAT-010106
- CID6442177
- CID:18477728
- SID:283537548
- FT-0654851
- A854650
- C107135
- Everolimus for system suitability A (Y0002354)
- Everolimus for System Suitability CRS (Y0002061)
- D000068338
- RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus
- (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy
- (1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
- (1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont
- RAD